Savient Pharmaceuticals, Inc. Files for Chapter 11, Seeks to Sell Assets for About $55 Million
U.S. biotech firm Savient Pharmaceuticals Inc filed for Chapter 11 bankruptcy protection in a Delaware court on Monday and said it has agreed to sell most of its assets to Sloan Holdings CV for about $55 million.
Help employers find you! Check out all the jobs and post your resume.